Bitcoin $50K Benchmark; Injective and InQubeta Seen as Whales Top Picks for 2024

If its recent bull rally is any indication, Bitcoin (BTC) has leveraged its past and future milestones to brighten up its present. After Bitcoin’s price hit $50,000 recently, market experts attributed the rise to its upcoming halving event and the massive boost it received due to BTC ETFs.

Ever since the US gave a green light to spot Bitcoin ETFs, the crypto sector has been in overdrive and the investment products have clocked phenomenal growth. The stellar investor flows come after months of waiting as the products struggled with regulatory challenges for ETFs while Bitcoin holders faced selling pressure.

Among altcoins, whales seem to be quite keen on tech-driven cryptos like Injective (INJ) and InQubeta (QUBE). While Injective is a blockchain system for developers, InQubeta is a decentralized crowdfunding resource for startups and their AI projects.

InQubeta’s rise comes at a time when analysts were already impressed with its presale growth. Some of them had even included it in the best cryptocurrency ICO lists. Its current presale funding stands at $9.9 million.

InQubeta: Helping AI Startups Leverage Defi

InQubeta is a DeFi-based ecosystem of resources for AI startups and their business development needs. The platform helps these startups build their brands, raise funds, create a market for their product, and find mentors.

The startups are carefully chosen by the InQubeta team based on how well their goals align with the platform’s vision for the AI sector.

InQubeta has released a native cryptocurrency, called the QUBE token, which serves as the sole mode of payment on the network. With the QUBE token, you don’t have to worry about what cryptos to buy now.  By choosing the QUBE token, crypto users can back AI-centric projects even before they hit the market. The token is built using the ERC-20 standard and is compatible with leading Web 3.0 wallets.

The token supply has been fixed at 1.5 billion and 65% of the stock is set to be released on the market via public sales. The rest goes towards financing the platform’s operations and meeting expenses like marketing, developer fees, legal expenses, and staking rewards.

QUBE is an emerging crypto with a deflationary model that saves holders’ returns from market volatility. The model lowers the asset supply whenever the market conditions are unfavorable to minimize price fluctuations. As the asset becomes hard to get, both the demand and price go up.

Bitcoin’s Most Significant Monetary Advancement: Edward Snowden

Bitcoin is a permissionless digital currency that can support quick online transactions. As the first cryptocurrency to be launched, Bitcoin has a loyal user base across countries.

Long-time Bitcoin user and whistleblower Edward Snowden recently called the cryptocurrency the “most significant monetary advancement” ever since coinage was created. He made the statement in a post on X (formerly Twitter) on February 19, 2024.

The launch of Bitcoin ETFs has bolstered its gains. On January 10, 11 ETFs were approved by the US SEC and since then they have netted billions in investment. Though discussions over the legal aspects of BTC ETFs continue, analysts suggest that Bitcoin will be among the whales’ top picks for 2024.

Injective to Join Hands With Solana for Omnichain Domain Name Service

Injective is a Layer 1 blockchain that powers fast and scalable dApps. These dApps can be customized using primitives and modules offered by a derivatives order book. Its native token INJ is considered one of the altcoins to watch out for this year because of its strong growth.

In a recent development, Injective announced that it would be partnering with the Solana Foundation to launch a domain name service for blockchains.

The strategic move would enable Injetive users to buy .sol names and even bridge it with Injective. An omnichain domain name service will pave the way for seamless user experiences for the users of both cryptocurrencies.

Conclusion

Since 2024 started, many analysts have shared insights on the best cryptocurrencies to buy this year. If you ask analysts, many are sticking to old favorites like Bitcoin, InQubeta, and Injective.

These experts are firm believers in the fact history repeats itself. Going by the three tokens’ strong growth in the past few months, analysts are quite optimistic about their trajectories.

Apart from the market reputation, these cryptocurrencies sport the best of technology which is reflected in the platforms’ commitment to keeping their users’ assets and privacy well guarded.

Visit InQubeta Presale

Exit mobile version